###begin article-title 0
The LIM-Only Protein FHL2 Mediates Ras-Induced Transformation through Cyclin D1 and p53 Pathways
###end article-title 0
###begin p 1
Conceived and designed the experiments: CL YW. Performed the experiments: CL YN FL CAR GS TX YW. Analyzed the data: CL YN CA MAB YW. Wrote the paper: CL MAB YW.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 229 233 229 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2</italic>
###xml 239 244 <span type="species:ncbi:10090">mouse</span>
Four and a half LIM-only protein 2 (FHL2) has been implicated in multiple signaling pathways that regulate cell growth and tissue homeostasis. We reported previously that FHL2 regulates cyclin D1 expression and that immortalized FHL2-null mouse embryo fibroblasts (MEFs) display reduced levels of cyclin D1 and low proliferative activity.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2</italic>
###xml 223 228 223 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 249 252 249 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 245 252 245 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 385 389 385 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2</italic>
###xml 482 485 482 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 609 612 609 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 605 612 605 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 786 789 786 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 826 830 826 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2</italic>
###xml 937 940 937 940 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
Here we address the contribution of FHL2 in cell transformation by investigating the effects of oncogenic Ras in FHL2-null context. We show that H-RasV12 provokes cell cycle arrest accompanied by accumulation of p53 and p16INK4a in immortalized FHL2-/- MEFs. These features contrast sharply with Ras transforming activity in wild type cell lines. We further show that establishment of FHL2-null cell lines differs from conventional immortalization scheme by retaining functional p19ARF/p53 checkpoint that is required for cell cycle arrest imposed by Ras. However, after serial passages of Ras-expressing FHL2-/- cells, dramatic increase in the levels of D-type cyclins and Rb phosphorylation correlates with the onset of cell proliferation and transformation without disrupting the p19ARF/p53 pathway. Interestingly, primary FHL2-null cells overexpressing cyclin D1 undergo a classical immortalization process leading to loss of the p19ARF/p53 checkpoint and susceptibility to Ras transformation.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
Our findings uncover a novel aspect of cellular responses to mitogenic stimulation and illustrate a critical role of FHL2 in the signalling network that implicates Ras, cyclin D1 and p53.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 252 255 252 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Hervy1">[1]</xref>
###xml 343 346 336 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Wixler1">[2]</xref>
###xml 348 351 341 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Gabriel1">[3]</xref>
###xml 416 419 409 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Park1">[4]</xref>
###xml 601 604 594 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Labalette1">[5]</xref>
###xml 855 858 848 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Muller1">[6]</xref>
###xml 860 863 853 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Morlon1">[7]</xref>
###xml 1094 1097 1084 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Morlon1">[7]</xref>
###xml 1099 1102 1089 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Muller2">[8]</xref>
###xml 1104 1107 1094 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Fimia1">[9]</xref>
###xml 1109 1113 1099 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-McLoughlin1">[10]</xref>
###xml 1115 1119 1105 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Chen1">[11]</xref>
###xml 1121 1125 1111 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Martin1">[12]</xref>
###xml 1127 1131 1117 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Wei1">[13]</xref>
###xml 1133 1137 1123 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Yang1">[14]</xref>
###xml 1139 1143 1129 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Gunther1">[15]</xref>
###xml 1145 1149 1135 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Philippar1">[16]</xref>
###xml 1341 1345 1331 1335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Kadrmas1">[17]</xref>
###xml 1557 1561 1547 1551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2</italic>
###xml 1725 1729 1712 1716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Gunther1">[15]</xref>
###xml 1731 1735 1718 1722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Kong1">[18]</xref>
###xml 1737 1741 1724 1728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Wixler2">[19]</xref>
###xml 551 556 <span type="species:ncbi:10090">mouse</span>
###xml 1572 1576 <span type="species:ncbi:10090">mice</span>
Four and a half LIM-only protein 2 (FHL2) is a multi-functional protein that shuttles between focal adhesion sites and nucleus. Focal adhesions are specialized adhesive junctions where integrin receptors for extracellular matrix (ECM) are concentrated [1]. FHL2 interacts with alpha- and beta-integrin subunits and focal adhesion kinase (FAK) [2], [3] and is involved in assembly of ECM proteins on the cell surface [4]. Deregulation of genes involved in focal adhesion, ECM-receptor interaction and response to external stimuli has been evidenced in mouse embryo fibroblasts (MEF) deficient for FHL2 [5], suggesting that FHL2 plays important roles in tissue physiology and homeostasis and in the transduction of signals emitted from extracellular environment. Indeed, in response to RhoA signals or serum stimulation, FHL2 is translocated to the nucleus [6], [7] where it acts as either transcription coactivator or corepressor in interaction with numerous transcription factors including the androgen receptor, AP1, CREB, PLZF, SKI, beta-catenin, FOXO1, Runx2 and serum response factor (SRF) [7], [8], [9], [10], [11], [12], [13], [14], [15], [16]. The ability of FHL2 to assemble multiple partners into protein complexes is attributed to its LIM-domain structure that serves as protein binding interface through double zinc finger motifs [17]. Thus, FHL2 participates in regulating expression of a large spectrum of genes involved in cell proliferation, differentiation, transformation and apoptosis. Despite absence of gross defects during development, FHL2-deficient mice harbor cardiac hypertrophy in response to beta-adrenergic stimulation, osteopenia due to decreased activity of osteoblasts and wound healing defect [15], [18], [19].
###end p 9
###begin p 10
###xml 209 212 209 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Labalette1">[5]</xref>
###xml 297 301 297 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2</italic>
###xml 542 547 542 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 547 550 547 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Labalette1">[5]</xref>
###xml 552 556 552 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Labalette2">[20]</xref>
###xml 747 751 747 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Paul1">[21]</xref>
###xml 916 920 916 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Wang1">[22]</xref>
###xml 1031 1035 1031 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Wei1">[13]</xref>
###xml 1037 1041 1037 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Wang1">[22]</xref>
###xml 1043 1047 1043 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Johannessen1">[23]</xref>
###xml 1049 1053 1049 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Martin2">[24]</xref>
###xml 1206 1209 1206 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Muller1">[6]</xref>
###xml 1211 1215 1211 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Heemers1">[25]</xref>
###xml 307 311 <span type="species:ncbi:10090">mice</span>
###xml 896 905 <span type="species:ncbi:10090">nude mice</span>
Several lines of evidence have implicated FHL2 in the control of cell proliferation. We have recently shown that FHL2 physically occupies the cyclin D1 promoter and directly stimulates cyclin D1 transcription [5]. Accordingly, we found reduced expression levels of cyclin D1 in MEFs isolated from FHL2-null mice. After spontaneous immortalization, these cells exhibited weak proliferative capacity associated with low expression levels of all D-type cyclins and cyclin E, as well as cyclin-dependent kinase (Cdk) inhibitors, in particular p16INK4a[5], [20]. It has been shown that FHL2 can inhibit the antiproliferative functions of the transcription factor E4F1 by inhibiting the transcription repressor function and p53 binding activity of E4F1 [21]. In gastric and colon cancer cell lines, suppression of FHL2 inhibited anchorage-dependent and -independent cell growth, and tumor formation in nude mice xenograft [22]. In line with its effects on cell growth, overexpression of FHL2 has been detected in various types of cancer [13], [22], [23], [24]. Moreover, androgen-induced nuclear accumulation of FHL2 in highly malignant prostate carcinoma has been linked to disease progression and poor outcome [6], [25].
###end p 10
###begin p 11
###xml 151 155 151 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2</italic>
###xml 283 288 283 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 297 301 297 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Serrano1">[26]</xref>
###xml 481 485 481 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Narita1">[27]</xref>
###xml 506 511 506 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 626 629 626 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 744 748 744 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Kamijo1">[28]</xref>
###xml 1045 1054 1045 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a/ARF</italic>
###xml 1061 1065 1061 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Sherr1">[29]</xref>
In this study, we sought to gain further insight into the role of FHL2 in neoplastic transformation by investigating the effects of oncogenic Ras in a FHL2-deficient context. In primary rodent cells, activated Ras mutant induces premature senescence associated with activation of p16INK4a and p53 [26]. Cellular senescence involves an essentially irreversible cell cycle arrest that is associated with heterochromatin formation mediated by the retinoblastoma (Rb) tumor suppressor [27]. The ARF/p53 and p16INK4a/Rb pathways are clearly critical for establishing the senescence growth arrest, and primary MEFs deficient for p19ARF and p53 exhibit resistance to Ras-induced senescence and are susceptible to transformation by activated Ras alone [28]. In general, cooperation of Ras and additional "immortalizing" factors is required for transformation of primary rodent cells. However, oncogenic Ras alone readily transforms immortalized cells lines, since 80% of these cells contain mutant p53, whereas most others sustain biallelic loss of the INK4a/ARF locus [29].
###end p 11
###begin p 12
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2</italic>
###xml 286 290 286 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2</italic>
###xml 415 419 415 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2</italic>
Here, we report that H-RasV12 provokes a cell cycle arrest in spontaneously immortalized FHL2-null cells, in contrast to cell transformation in wild type (wt) counterparts. The cell growth arrest induced by Ras is controlled by p53 which remains wt after spontaneous immortalization of FHL2-null cells. We found that under continuous Ras-mediated mitogenic stimulation, D-type cyclins are dramatically increased in FHL2-deficient cells, resulting in reversal of the growth arrest without disrupting the ARF/p53 checkpoint.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
###xml 46 49 46 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 42 49 42 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
Absence of foci formation in immortalized FHL2-/- fibroblasts upon H-RasV12 expression
###end title 14
###begin p 15
###xml 120 123 120 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 116 123 116 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Chu1">[30]</xref>
###xml 161 164 161 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Labalette1">[5]</xref>
###xml 317 320 317 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 313 320 313 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 566 569 566 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 562 569 562 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 576 591 576 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g001">Figs. 1A and 1B</xref>
###xml 683 690 683 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g001">Fig. 1C</xref>
###xml 832 835 832 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 828 835 828 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 881 885 881 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2</italic>
###xml 1026 1033 1026 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g001">Fig. 1B</xref>
###xml 1070 1074 1070 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2</italic>
###xml 1194 1209 1194 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g001">Figs. 1A and 1B</xref>
We have recently reported the establishment of spontaneously immortalized cell lines from primary MEFs derived from FHL2-/- embryos [30] by using a 3T3 protocol [5]. To assess the effects of FHL2 deficiency on cell transformation, we expressed the oncogenic form H-RasV12 in three independent immortalized wt and FHL2-/- MEF cell lines. Transiently transfected cells were analyzed for the loss of contact inhibition by focus formation assays. As expected, numerous colonies were detected in wt fibroblasts, but strikingly, no colonies developped in immortalized FHL2-/- MEFs (Figs. 1A and 1B), despite similar levels of Ras expression in these cell lines as shown by immunoblotting (Fig. 1C). To confirm that FHL2 deficiency was directly involved in this phenotype, we then re-expressed FHL2 from a retroviral vector in primary FHL2-/- MEFs at early passage. Continuous passage of FHL2-restored MEFs readily gave rise to established 3T3 cell lines in which the levels of FHL2 protein were significantly lower than in wt MEFs (Fig. 1B). Transfection of the Ras vector in FHL2-restored MEF lines resulted in colony formation, although transformation efficiency was about half of that in wt MEFs (Figs. 1A and 1B). Thus, low level FHL2 expression was sufficient to restore the capacity of immortalized MEFs to undergo deregulated growth and loss of contact inhibition in response to oncogenic Ras. These results indicate that FHL2 deficiency impairs Ras-induced transformation of immortalized MEFs.
###end p 15
###begin title 16
###xml 46 49 46 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 42 49 42 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
Absence of foci formation in immortalized FHL2-/- MEFs upon expression of H-RasV12.
###end title 16
###begin p 17
###xml 297 300 297 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 293 300 293 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 418 422 418 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2</italic>
###xml 436 439 436 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 432 439 432 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 693 697 691 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2</italic>
(A) Focus formation assay of MEFs transiently transfected with H-RasV12 or empty vector. Plates were stained with Giemsa at 3 weeks after transfection. Data are representative of at least 3 independent experiments using 3 spontaneously immortalized clones. To restore FHL2 expression, primary FHL2-/- MEFs were infected with a retrovirus expressing FHL2 (pBabeFHL2puro) and cultured according to the 3T3 protocol. Two FHL2-restored FHL2-/- cell pools were obtained and used in the study. pBabe vector was used as a control (Babe). (B) Chart depicting at least three independent experiments. Mean colony numbers+/-standard deviation are shown. Bottom: Immunoblot analysis of FHL2 expression in FHL2-restored cell line. (C) Analysis of H-RasV12 expression in MEFs transfected with either empty (V) or H-RasV12 (R) expression vector. Samples were processed for immunoblotting 48 h after transfection. Actin was used as loading control.
###end p 17
###begin title 18
###xml 57 60 57 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 53 60 53 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
H-RasV12 induces a cell cycle arrest in immortalized FHL2-/- MEFs
###end title 18
###begin p 19
###xml 126 130 126 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Downward1">[31]</xref>
###xml 230 233 230 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 226 233 226 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 238 243 238 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2-</italic>
###xml 379 384 379 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2-</italic>
###xml 527 534 527 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g002">Fig. 2A</xref>
###xml 611 615 611 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2</italic>
###xml 753 758 753 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2-</italic>
###xml 578 587 <span type="species:ncbi:10090">nude mice</span>
###xml 667 671 <span type="species:ncbi:10090">mice</span>
###xml 710 714 <span type="species:ncbi:10090">mice</span>
It has been shown that oncogenic Ras can induce either transformation, senescence or apoptosis, depending on the cell context [31]. To further investigate the effects of Ras in the context of FHL2 deficiency, immortalized wt, FHL2-/- and FHL2-restored cells were infected with pBabe-RasV12 or control pBabe retrovirus and selected for drug resistance. Both Ras-transduced wt and FHL2-restored MEFs exhibited thin, elongated, and spindle-like morphology and loss of contact inhibition characteristic of transformed fibroblasts (Fig. 2A). Moreover, when injected s.c. into BALB/c nude mice, Ras-transduced wt and FHL2-restored fibroblasts generated large tumors in 6/6 mice. In control experiment, none of the 6 mice injected with vector-transduced wt or FHL2-restored cells developed tumors.
###end p 19
###begin title 20
###xml 55 58 55 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 51 58 51 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
H-RasV12 induces cell cycle arrest in immortalized FHL2-/- MEFs.
###end title 20
###begin p 21
###xml 25 28 25 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 21 28 21 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 37 40 37 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 33 41 33 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup>-</italic>
###xml 161 164 161 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 157 164 157 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 237 242 234 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lac Z</italic>
###xml 255 259 252 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2</italic>
###xml 344 347 341 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 340 347 337 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 423 427 420 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 432 437 429 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 506 509 503 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 502 509 499 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
(A) Immortalized wt, FHL2-/- and FHL2-/--restored MEFs were infected with pBabe-RasV12 or control pBabe retrovirus and selected for drug resistance. (B) All FHL2-/- cells were positive in beta-galactosidase assay due to the insertion of Lac Z cDNA at the FHL2 locus. (C) Ki-67 immunofluorescence analysis in vector- and H-RasV12-transduced FHL2-/- MEFs. Nuclei were counterstained with DAPI. (D) Expression of Ras, p53, p21CIP1, p16INK4a and cyclin D1 in H-RasV12- (R) or vector- (V) transduced wt and FHL2-/- cell lines. Equal amounts of protein extracts were analyzed by immunoblotting.
###end p 21
###begin p 22
###xml 107 110 107 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 103 110 103 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 183 190 183 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g002">Fig. 2A</xref>
###xml 330 337 330 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g001">Fig. 1A</xref>
###xml 362 365 362 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 358 365 358 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 476 480 473 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Dimri1">[32]</xref>
###xml 563 567 560 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lacZ</italic>
###xml 593 597 590 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2</italic>
###xml 619 623 616 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2</italic>
###xml 634 638 631 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Chu1">[30]</xref>
###xml 692 695 686 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 688 695 682 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 729 736 723 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g002">Fig. 2B</xref>
###xml 629 633 <span type="species:ncbi:10090">mice</span>
In sharp contrast, H-RasV12 transduction produced very different morphological changes in immortalized FHL2-/- cell lines. Cells in these cultures were large, flat and nonrefractile (Fig. 2A), evoking a senescent-like morphology that could not be detected in transient assays, in which non-transfected cells were predominant (see Fig. 1A). Three independent FHL2-/- lines displayed similar morphology upon Ras expression (data not shown). However, beta-galactosidase activity [32] could not be tested as a senescence-associated marker in this system, because the lacZ cDNA was inserted at the FHL2 locus for generating FHL2-null mice [30], resulting in beta-galactosidase activity in all FHL2-/- cells even at acidic conditions (Fig. 2B).
###end p 22
###begin p 23
###xml 77 80 77 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 73 80 73 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 288 291 288 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 284 291 284 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 395 398 395 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 391 398 391 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 409 416 409 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g002">Fig. 2C</xref>
###xml 616 620 616 620 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 628 633 628 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 816 820 816 820 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 828 833 828 833 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 841 844 841 844 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 837 844 837 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 872 879 872 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g002">Fig. 2D</xref>
###xml 904 909 904 909 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 935 938 935 938 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 931 938 931 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 945 948 945 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Labalette1">[5]</xref>
###xml 950 957 950 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g002">Fig. 2D</xref>
###xml 1008 1013 1008 1013 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 1093 1097 1093 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Beausjour1">[33]</xref>
###xml 1119 1124 1119 1124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 1139 1142 1139 1142 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1135 1142 1135 1142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 1370 1374 1370 1374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Serrano1">[26]</xref>
###xml 1376 1380 1376 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Liu1">[34]</xref>
###xml 1448 1451 1448 1451 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1444 1451 1444 1451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 1459 1466 1459 1466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g002">Fig. 2D</xref>
###xml 1532 1535 1532 1535 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1528 1535 1528 1535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 1570 1577 1570 1577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g002">Fig. 2D</xref>
###xml 1579 1582 1579 1582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Labalette1">[5]</xref>
###xml 1075 1080 <span type="species:ncbi:9606">human</span>
To better characterize the phenotype of H-RasV12-transduced immortalized FHL2-/- cells, we first examined whether these cells were growth arrested by monitoring their proliferative activity, using immunostaining with a Ki-67 specific antibody. While positive signals were observed in FHL2-/- cells transduced with the pBabe vector, no Ki-67-positive cell was detected in H-RasV12-transduced FHL2-/- cultures (Fig. 2C). We then assessed the expression of genes that are specifically associated with the G1 arrest induced by oncogenic Ras in fibroblasts, namely p53 and the cyclin-dependent kinase (Cdk) inhibitors p21CIP1 and p16INK4a that promote cell cycle arrest via the Rb tumor suppressor pathway. Immunoblotting analysis revealed that expression of oncogenic Ras was associated with increased levels of p53, p21CIP1 and p16INK4a in FHL2-/- MEFs, but not in wt cells (Fig. 2D). The basal level of p16INK4a was extremely low in FHL2-/- cells [5] (Fig. 2D). It has been demonstrated that high levels of p16INK4a provide a dominant second barrier to the unlimited growth of human fibroblasts [33]. The induction of p16INK4a by Ras in FHL2-/- cells may provide an alternative mechanism of p53 activation for cell cycle exit. In addition, consistent with previous reports showing that cyclin D1 is activated by oncogenic Ras in both senescent and transformed fibroblasts [26], [34], we found equally high level expression of cyclin D1 in wt and FHL2-/- cells (Fig. 2D). The fold increase of cyclin D1 by Ras was more dramatic in FHL2-/- cells, given its low basal level (Fig. 2D) [5].
###end p 23
###begin p 24
###xml 132 135 132 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 128 135 128 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 209 214 209 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 361 365 361 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Blagosklonny1">[35]</xref>
Based on the observed morphological and biochemical changes, it seems likely that Ras-induced cell cycle arrest of immortalized FHL2-/- cells was triggered by a senescent-like program that involves p53 and p16INK4a. This cell cycle arrest corresponds to the model of hypermitogenic arrest that is associated with a 'large cell' morphology and protein synthesis [35].
###end p 24
###begin title 25
###xml 17 20 17 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 13 20 13 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 36 39 36 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 54 63 54 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a/ARF</italic>
Immortalized FHL2-/- MEFs retain wt p53 and an intact INK4a/ARF locus
###end title 25
###begin p 26
###xml 166 175 166 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a/ARF</italic>
###xml 182 186 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Sherr1">[29]</xref>
###xml 275 278 275 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 271 278 271 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 328 335 328 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g002">Fig. 2D</xref>
###xml 793 800 793 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g003">Fig. 3A</xref>
###xml 948 951 948 951 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 944 951 944 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 964 971 964 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g003">Fig. 3A</xref>
###xml 1123 1126 1123 1126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1119 1126 1119 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 1251 1254 1251 1254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1247 1254 1247 1254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 1364 1367 1364 1367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1360 1367 1360 1367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
Previous studies have shown that 80% of spontaneously immortalized MEF cell lines harbor mutant p53 alleles, whereas most of the others sustain biallelic loss of the INK4a/ARF locus [29]. However, the low basal level of p53 and its activation by H-RasV12 in immortalized FHL2-/- MEFs suggest that these cells may harbor wt p53 (Fig. 2D). We assessed the p53 status of immortalized MEFs by treating cells with doxorubicin (doxo), a DNA damage-inducing drug that induces the up-regulation of wt p53, but has no effect on the already stabilized p53 mutants. Detection of p53 was optimized by immunoprecipitating the protein from cell lysates before immunoblotting. In established wt cell lines, basal p53 levels were high in the absence of any stimulus, and did not increase in response to doxo (Fig. 3A), reflecting the hallmarks of p53 mutants. In sharp contrast, p53 was produced at low levels and was significantly induced by doxo in all five FHL2-/- cell lines (Fig. 3A), consistent with the presence of wt p53. We therefore went on to analyze the p53 gene by direct PCR sequencing of genomic DNA in four independent FHL2-/- cell lines. Using a set of five PCR fragments covering exons 4 to 10, both strands of each exon were sequenced. Of four FHL2-/- cell lines analyzed, we did not detect any mutation, which confirms the wt status of p53 in immortalized FHL2-/- cells.
###end p 26
###begin title 27
###xml 52 55 52 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 48 55 48 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
Analysis of the p53/ARF pathway in immortalized FHL2-/- MEFs.
###end title 27
###begin p 28
###xml 223 226 223 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 219 226 219 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 447 450 447 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 611 614 611 614 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 607 614 607 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 924 927 924 927 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 920 927 920 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 1065 1068 1065 1068 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1061 1068 1061 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 518 538 <span type="species:ncbi:10566">Human papillomavirus</span>
(A) Functional analysis of the p53 protein. After induction by doxorubicin (doxo), p53 was immunoprecipitated from immortalized MEFs and analyzed by immunoblotting. Wild type clones are indicated by capital letters and FHL2-/- clones by lower-case letters. p53 induction was determined as the ratio of the relative p53/actin intensities after doxo treatment to p53/actin intensities without doxo in each cell line. (B) Western blot analysis of p19ARF expression in seven immortalized clones of each FHL2 genotype. (C) Human papillomavirus E6 oncoprotein restores Ras-mediated transformation in immortalized FHL2-/- MEFs. Cells were infected with E6-expressing retrovirus (HPVE6) or control virus (Babe), and then transiently transfected with H-RasV12 plasmid or control vector, cultured for 3 weeks without splitting and stained. Data are representative of three independent experiments in two independent E6-transduced FHL2-/- MEF clones. (D) Dominant negative p53 (p53DD) was expressed alone or coexpressed with H-RasV12 by retroviral vectors in immortalized FHL2-/- MEFs.
###end p 28
###begin p 29
###xml 15 18 15 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2</italic>
###xml 163 170 163 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g003">Fig. 3B</xref>
###xml 189 192 189 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 259 262 259 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 255 262 255 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 326 329 326 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 371 375 371 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Kamijo2">[36]</xref>
###xml 418 423 418 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 452 455 452 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Labalette1">[5]</xref>
###xml 507 516 507 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a/ARF</italic>
###xml 572 575 572 575 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 636 639 636 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Analyses of p19ARF expression in immortalized FHL2-null cell lines reproducibly showed the presence of the protein in all cell lines, regardless of FHL2 genotype (Fig. 3B). However, the p19ARF protein was generally present in larger amounts in wt than in FHL2-/- cell lines, in agreement with previous reports showing that p19ARF is up-regulated in cells with mutant p53 [36]. As reported previously, low levels of p16INK4a were detected in all clones [5]. Based on these observations, we conclude that the INK4a/ARF locus remained intact in these cells. Disruption of p19ARF or p53 is therefore not required for immortalization of FHL2-/- MEFs.
###end p 29
###begin title 30
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2</italic>
Microarray analysis shows up-regulation of p53 target genes in FHL2-deficient cells
###end title 30
###begin p 31
###xml 59 62 59 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 55 62 55 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 199 202 199 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 195 202 195 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 309 312 309 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Labalette1">[5]</xref>
###xml 355 358 355 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 351 358 351 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 528 532 528 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Subramanian1">[37]</xref>
###xml 624 628 624 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Ongusaha1">[38]</xref>
###xml 714 717 714 717 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 710 717 710 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 725 732 725 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g004">Fig. 4A</xref>
###xml 798 802 798 802 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 884 888 884 888 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 987 991 987 991 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 999 1002 999 1002 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 995 1002 995 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 1102 1106 1102 1106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 1136 1140 1136 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Wu1">[39]</xref>
###xml 1202 1205 1202 1205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1198 1205 1198 1205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 1212 1219 1212 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g004">Fig. 4B</xref>
###xml 1488 1492 1488 1492 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 1521 1525 1521 1525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-elDeiry1">[40]</xref>
###xml 1608 1612 1608 1612 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 1649 1653 1649 1653 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 1710 1713 1710 1713 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1706 1713 1706 1713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 1721 1728 1721 1728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g004">Fig. 4C</xref>
###xml 1899 1903 1899 1903 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2</italic>
###xml 278 283 <span type="species:ncbi:10090">Mouse</span>
To confirm that the p53 pathway remained functional in FHL2-/- cell lines, we assessed the expression of p53 target genes at the whole-genome level by comparing gene expression profiles of three FHL2-/- cell lines with those of three immortalized wt MEF clones using Affymetrix Mouse Genome 430 2.0 microarray[5]. Up-regulation of p53 target genes in FHL2-/- cells was evidenced by Gene Set Enrichment Analysis (GSEA), a computational method for assessing enrichment of a predefined gene list in one class compared with another [37]. Using a list of thirty one p53 target genes of the Molecular Signatures Database (MSigDB) [38] as gene set, we found that 61% of these genes were significantly up-regulated in FHL2-/- cells (Fig. 4A). Specifically, several well-studied p53 target genes such as p21CIP1, Fas and cyclin G1 were increased in cells lacking FHL2. As the Cdk inhibitor p21CIP1 is a downstream effector of p53, we then analyzed the expression of genes that are targeted by p21CIP1 in FHL2-/- cells. For GSEA, we used a set of 39 genes that were down-regulated after ectopic expression of p21CIP1 in ovarian cancer cell lines [39], and found decreased expression in 61% of these genes in FHL2-/- MEFs (Fig. 4B). It included genes encoding aurora kinases, Mcm proteins, Kntc1, Cep55 and Cdc25b that are implicated in DNA replication, activation of M-phase, kinetochore assembly and chromosome segregation. Downregulation of these genes is consistent with the known effects of p21CIP1 on G1 and G2/M phase arrest [40]. Real-time RT-PCR analysis confirmed altered expression of p53 targets such as p21CIP1 and Pltp, and down-regulation of p21CIP1 downstream genes such as Ube2c, Ccdc99 and Tubb3 in FHL2-/- cells (Fig. 4C). Taken together, genome-wide analysis firmed up the functional activity of p53 and provided insight into the impact of functional p53 on gene expression in immortalized FHL2-null cells.
###end p 31
###begin p 32
###xml 25 29 25 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2</italic>
###xml 206 207 206 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 289 292 289 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 727 728 725 726 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 790 794 788 792 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 848 849 846 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 974 977 970 973 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1124 1128 1120 1124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 1202 1205 1198 1201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1198 1205 1194 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
Expression of p53 and p21CIP1 target genes in FHL2-null cells (A) Left: GSEA plot using a gene set of up-regulated p53-dependent genes from the Molecular Signatures Database (MSigDB) (NES = 2.35, FDR<0.01, p<0.0001). Enrichment score (ES) reflects the correlation of the gene set with FHL2-/- (KO) and WT genotypes. Middle: Core group of genes of the up-regulated p53-dependent gene set that contributed to the ES. The fold change (KO/WT) value for genes that have more than one probe set corresponds to the mean value. Right: Expression profile of the deregulated genes at fold change >/=1.4 in 3 different clones for each genotype. Data are plotted as a heatmap where red and blue correspond to high and low expression in log2-transformed scale. (B) GSEA Analysis using down-regulated p21CIP1-dependent gene set of MSigDB (NES = -2.25, FDR<0.01, p<0.0001). Expression profile of the top down-regulated genes at fold change </=0.8 that are differently expressed in the FHL2-/- compared to wt clones. Abbreviations: NES: normalized enrichment score, FDR: false discovery rate. (C) Quantitative RT-PCR analysis of Cdkn1a (p21CIP1), Pltp, Ube2c, Ccdc99, Tubb3 transcripts in three independent wt and FHL2-/- immortalized clones. Data were normalized to 18S RNA. Results are expressed as relative expression of each gene/18S RNA assuming wt cells as 1.0. Average values and standard deviations for three independent experiments are shown.
###end p 32
###begin title 33
###xml 80 83 80 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 76 83 76 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
Inactivation of p53 confers susceptibility to Ras-induced transformation in FHL2-/- cells
###end title 33
###begin p 34
###xml 20 23 20 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 102 106 102 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Ferbeyre1">[41]</xref>
###xml 200 203 200 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 196 203 196 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 418 421 418 421 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 414 421 414 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 491 498 491 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g003">Fig. 3C</xref>
###xml 622 626 622 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Hahn1">[42]</xref>
###xml 669 672 669 672 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 665 672 665 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 753 760 753 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g003">Fig. 3D</xref>
###xml 833 842 833 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2-null</italic>
###xml 948 951 948 951 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 944 951 944 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 1075 1078 1075 1078 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1071 1078 1071 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 246 266 <span type="species:ncbi:10566">human papillomavirus</span>
###xml 794 803 <span type="species:ncbi:10090">nude mice</span>
###xml 886 890 <span type="species:ncbi:10090">mice</span>
###xml 925 929 <span type="species:ncbi:10090">mice</span>
Integrity of the p19ARF/p53 pathway is required for induction of cellular senescence by oncogenic Ras [41]. To determine whether p53 inactivation could alter the effects of H-RasV12 expression in FHL2-/- MEFs, we first used the E6 oncoprotein of human papillomavirus-16 that causes p53 degradation and abolishes p53-mediated checkpoints. Retroviral transduction of E6 before transient transfection of immortalized FHL2-/- cell lines with H-rasV12 resulted in efficient colony formation (see Fig. 3C), thus allowing efficient transformation of these cells. Moreover, co-expression of a dominant negative form of p53, p53DD [42] and H-RasV12 by retroviral vectors in FHL2-/- cells resulted in thin, elongated, and spindle-like transformed morphology (see Fig. 3D). When injected s.c. into BALB/c nude mice, Ras- and p53DD-cotransduced FHL2-null fibroblasts induced tumor formation in 4/4 mice, whereas no tumor developped in 4 mice injected with FHL2-/- cells transduced with p53DD alone. Thus, p53 inactivation was sufficient to restore the susceptibility of immortalized FHL2-/- MEFs to Ras-mediated transformation.
###end p 34
###begin title 35
###xml 62 65 62 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 58 65 58 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
The cell cycle arrest induced by H-RasV12 in immortalized FHL2-/- MEFs is reversible
###end title 35
###begin p 36
###xml 37 40 37 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 33 40 33 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 200 203 200 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 196 203 196 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 432 439 432 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g005">Fig. 5A</xref>
###xml 538 541 538 541 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 534 541 534 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 620 623 620 623 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 616 623 616 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 590 599 <span type="species:ncbi:10090">nude mice</span>
The morphology of Ras-transduced FHL2-/- cells evoked cellular senescence that involves an essentially irreversible cell cycle arrest. When cultured with the 3T3 protocol, however, Ras-transduced FHL2-/- cells resumed proliferation after 5 passages. At passage 10, thin and spindle-like morphology characteristic of transformed fibroblasts appeared, in sharp contrast to the initial large cell size and flat "senescent" morphology (Fig. 5A, compare passage 10 to passage 0). Similar data were obtained in 3 independent Ras-expressing FHL2-/- cell lines (data not shown). When injected into nude mice, Ras-transduced FHL2-/- cells at passage 10 gave rise to tumors in 3/3 animals.
###end p 36
###begin title 37
###xml 61 64 61 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 57 64 57 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
Reversal of the cell cycle arrest in H-RasV12-transduced FHL2-/- MEFs.
###end title 37
###begin p 38
###xml 314 321 314 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g003">Fig. 3A</xref>
###xml 388 391 388 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 384 391 384 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
(A) The indicated cell lines transduced by H-RasV12 or control vector are shown at cell cycle arrest stage (passage 0) and after reversal of the cell cycle arrest (passage 10). (B) Analysis of the p53 protein in cells at passage 10 after H-RasV12 transduction. Cells were treated with doxorubicine as described in Fig. 3A. (C) Western blot analysis of cell cycle regulators in wt and FHL2-/- cell lines at passage 10 after transduction with H-RasV12 (R) or empty vector (V). (D) Growth curves of the indicated cell lines after reversal. Equal numbers of cells were initially plated in triplicate wells, and cells were counted at indicated times. Mean values+/-standard deviation from three independent experiments are shown. Data presented are representative of 3 independent H-RasV12- and vector-expressing MEF lines.
###end p 38
###begin p 39
###xml 39 42 39 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 35 42 35 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 201 204 201 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 197 204 197 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 276 279 276 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 272 279 272 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 437 440 437 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 433 440 433 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 495 498 495 498 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 491 498 491 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 570 577 570 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g002">Fig. 2D</xref>
###xml 655 658 655 658 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 651 658 651 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 738 741 738 741 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 734 741 734 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 762 769 762 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g005">Fig. 5B</xref>
###xml 913 916 913 916 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 909 916 909 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 1064 1071 1064 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g005">Fig. 5B</xref>
###xml 1095 1104 1095 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a/ARF</italic>
###xml 1141 1146 1141 1146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 1154 1157 1154 1157 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 1195 1200 1195 1200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 1282 1285 1282 1285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 1339 1346 1339 1346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g005">Fig. 5C</xref>
###xml 1427 1430 1427 1430 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1423 1430 1423 1430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 1482 1485 1482 1485 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
The transient cell cycle arrest of FHL2-/- cells contrasts with the permanent cell cycle arrest induced by Ras in primary rodent cells. To determine the role of p53 in the escape of Ras-transduced FHL2-/- cells from growth arrest, we measured the protein levels of p53 in FHL2-/--transformed cells. After treatment with doxo, cell lysates were analyzed for p53 expression by immunoblotting. The basal levels of p53 in Ras-transduced FHL2-/- cells were higher than those in vector-transduced FHL2-/- cells, consistent with the induction of p53 in these cells by Ras (see Fig. 2D). However, p53 was still significantly induced by doxo in Ras-transduced FHL2-/- cells after reversal of the growth arrest, as well as in vector-transduced FHL2-/- control cell lines (Fig. 5B). These data suggested that p53 remained wt, which was further confirmed by sequencing p53 exons 4 to 10 in three different Ras-transduced FHL2-/- cell lines (data not shown). In contrast, no p53 induction by doxo was detected in Ras-transduced wt cells, as expected for the p53 mutant status (Fig. 5B). We then assessed the INK4a/ARF locus by examining expression of p16INK4a and p19ARF by immunoblotting. High levels of p16INK4a were maintained in these cells after reversal, whereas a moderate increase of p19ARF expression was detected in the same cell population (Fig. 5C). These data indicate that the reversal of Ras-imposed cell cycle arrest in FHL2-/- cells was not associated with disruption of the p19ARF/p53 pathway.
###end p 39
###begin p 40
###xml 164 167 164 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Labalette1">[5]</xref>
###xml 247 251 247 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Serrano1">[26]</xref>
###xml 253 257 253 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Liu1">[34]</xref>
###xml 370 373 370 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 366 373 366 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 491 498 491 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g005">Fig. 5C</xref>
###xml 535 539 535 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Yu1">[43]</xref>
###xml 664 667 664 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 660 667 660 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 675 682 675 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g005">Fig. 5C</xref>
###xml 764 771 764 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g005">Fig. 5C</xref>
###xml 840 843 840 843 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 836 843 836 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 945 952 945 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g005">Fig. 5D</xref>
###xml 981 984 981 984 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 977 984 977 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 1269 1272 1269 1272 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
###xml 1338 1341 1338 1341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
We have previously reported that FHL2 deficiency in immortalized MEFs is associated with low levels of cyclins D1, D2, D3 and E, and with hypophosphorylation of Rb [5]. The ability of Ras to activate cyclin D1 in both senescent and immortal cells [26], [34] prompted us to examine the expression of cyclin D1 and several other cell cycle regulators in Ras-tranduced FHL2-/- cells after reversal. We found that oncogenic Ras induced up-regulation of cyclin D1, but not D2 and D3 in wt cells (Fig. 5C), in agreement with previous report [43]. Strikingly, drastic induction was observed not only for cyclin D1, but also for cyclins D2, D3 and E in Ras-expressing FHL2-/- cells (Fig. 5C). In consequence, Rb phosphorylation was significantly augmented in these cells (Fig. 5C). Expression of H-RasV12 considerably potentiated the growth of FHL2-/- cells, although the proliferative rate remained slightly lower than that of Ras-transduced wt cells (Fig. 5D). Thus, in immortalized FHL2-/- cells, Ras-induced cell cycle arrest appeared to be a transient phenotype, and escape of the cell cycle arrest might be triggered by activation of G1-S cyclins by prolonged Ras expression, in turn leading to Rb phosphorylation. These observations indicate that if integrity of the p19ARF/p53 pathway is crucial for establishing cell cycle arrest in FHL2-/- cell lines upon Ras expression, inactivation of Rb by increased cyclin/Cdk activity may be sufficient to reset their replicative lifespan. The resumed proliferative capacity diverts Ras activity to cell transformation.
###end p 40
###begin title 41
###xml 67 70 67 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 63 70 63 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
Ectopic expression of cyclin D1 restores the susceptibility of FHL2-/- cells to transformation by oncogenic Ras
###end title 41
###begin p 42
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2</italic>
###xml 119 122 119 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 102 122 102 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin D1-HA/FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 153 156 153 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 149 156 149 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 224 231 224 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g006">Fig. 6A</xref>
###xml 233 236 233 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Labalette1">[5]</xref>
###xml 405 408 405 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Labalette1">[5]</xref>
###xml 583 586 583 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 579 586 579 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 607 610 607 610 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 603 610 603 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 614 626 614 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin D1-HA</italic>
###xml 631 634 631 634 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 627 634 627 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 661 673 661 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin D1-HA</italic>
###xml 678 681 678 681 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 674 681 674 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 780 787 780 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g006">Fig. 6B</xref>
###xml 869 872 869 872 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 865 872 865 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 884 891 884 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g002">Fig. 2A</xref>
###xml 981 993 981 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin D1-HA</italic>
###xml 998 1001 998 1001 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 994 1001 994 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 1100 1112 1100 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin D1-HA</italic>
###xml 1117 1120 1117 1120 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1113 1120 1113 1120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 1159 1166 1159 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g006">Fig. 6C</xref>
To directly evaluate the role of cyclin D1 in transformation of FHL2-null cells, we used immortalized cyclin D1-HA/FHL2-/- MEFs derived from primary FHL2-/- cells transduced with a retroviral vector for HA-tagged cyclin D1 (Fig. 6A) [5]. We have previously shown that expression of cyclins D1, D2, D3 and E and Rb phosphorylation as well a cell proliferation were restored to normal levels in these cells [5]. The effects of cyclin D1 restoration on the cellular response to mitogenic stimulation were evaluated after retroviral-mediated transfer of H-RasV12 in immortalized wt, FHL2-/-, pBabe-infected FHL2-/-and cyclin D1-HA/FHL2-/- cells. The Ras-transduced cyclin D1-HA/FHL2-/- cells showed a thin, elongated and spindle-like morphology similar to wt MEFs transformed by Ras (Fig. 6B), in contrast with the senescent morphology of Ras-transduced pBabe-infected FHL2-/- cells (see Fig. 2A and data not shown). When assayed for their ability to grow in soft agar, Ras-transduced cyclin D1-HA/FHL2-/- cells formed colonies at similar efficiency as wt MEFs (0.04%), whereas no colony was detected in cyclin D1-HA/FHL2-/- cells infected with the empty vector (Fig. 6C).
###end p 42
###begin title 43
###xml 17 20 17 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 13 20 13 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
Immortalized FHL2-/- MEFs stably expressing cyclin D1 are susceptible to transformation by oncogenic Ras.
###end title 43
###begin p 44
###xml 55 58 55 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 51 58 51 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 266 269 266 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 249 269 249 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin D1-HA/FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 379 380 379 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 482 485 482 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 465 485 465 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin D1-HA/FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 625 632 625 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g003">Fig. 3A</xref>
(A) Increased cyclin D1 expression in immortalized FHL2-/- MEFs after introduction of cyclin D1-HA transgene was confirmed by immunoblotting with anti-cyclin D1 and anti-HA antibodies. (B) Representative phase contrast images of immortalized wt and cyclin D1-HA/FHL2-/- cell lines transduced with H-RasV12 or empty vector. (C) Soft agar assay. Cells were initially seeded at 5x104 cells/plate and cultured for 10 days. Images are representative of three wt and two cyclin D1-HA/FHL2-/- cell lines transduced with H-RasV12. (D) Western blot analysis of p53 induction by doxorubicin in the indicated cell lines as described in Fig. 3A.
###end p 44
###begin p 45
###xml 29 41 29 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin D1-HA</italic>
###xml 46 49 46 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 42 49 42 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 238 250 238 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin D1-HA</italic>
###xml 255 258 255 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 251 258 251 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 392 399 392 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g006">Fig. 6D</xref>
###xml 474 477 474 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 457 477 457 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin D1-HA/FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 546 549 546 549 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 542 549 542 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 729 732 729 732 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 725 732 725 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
The observed susceptibity of cyclin D1-HA/FHL2-/- cell lines to Ras-induced transformation led us to examine the p53 status of these cells by comparing p53 expression levels in basal conditions and after doxo treatment. The p53 levels in cyclin D1-HA/FHL2-/- cells were as high as those in wt MEFs in the absence of treatment, and did not increase in response to doxo, reflecting mutant p53 (Fig. 6D), and similar results were obtained with two independent cyclin D1-HA/FHL2-/- cell pools (data not shown). In contrast, pBabe vector-infected FHL2-/- MEFs showed typical features of wt p53, with low basal levels of p53 and positive response to doxo stimulation. These findings suggest that restoration of cyclin D1 re-routed FHL2-/- cells to the common immortalization pathway associated with loss of p53 function and sensitivity to Ras transformation.
###end p 45
###begin title 46
Discussion
###end title 46
###begin p 47
###xml 91 94 91 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 474 479 474 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</italic>
###xml 486 490 486 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Sherr1">[29]</xref>
###xml 607 611 607 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2</italic>
###xml 170 175 <span type="species:ncbi:10090">mouse</span>
This study, showing that oncogenic Ras provokes a proliferative arrest in immortalized FHL2-/- MEFs, uncovers a yet undocumented effect of Ras in the context of immortal mouse cell lines. We found that loss of FHL2 signalling confers immortalized MEFs the ability to retain an intact ARF/p53 checkpoint that is essential for Ras induction of cell cycle arrest, at difference with wt cell lines in which the ARF/p53 pathway is disrupted by mutation of p53 or deletion of the INK4a locus [29]. We provide evidence that the cyclin D/Rb pathway is critical in the regulation of cell cycle and transformation in FHL2-deficient cells.
###end p 47
###begin title 48
###xml 121 124 121 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Low levels of cyclin D may override the requirement for disruption of the ARF/p53 checkpoint during establishment of FHL2-/- cell lines
###end title 48
###begin p 49
###xml 92 95 92 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 88 95 88 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 179 184 179 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2-</italic>
###xml 222 225 222 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 218 225 218 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 364 367 364 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 360 367 360 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 513 520 513 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003761-g005">Fig. 5C</xref>
###xml 525 528 525 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Labalette1">[5]</xref>
###xml 589 593 589 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Blagosklonny1">[35]</xref>
###xml 835 839 835 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2</italic>
###xml 1384 1387 1384 1387 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1380 1387 1380 1387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 1468 1480 1468 1480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin D1-HA</italic>
###xml 1485 1488 1485 1488 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1481 1488 1481 1488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 1778 1787 1778 1787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin D1</italic>
###xml 1789 1791 1789 1791 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D2</italic>
###xml 1796 1798 1796 1798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D3</italic>
###xml 1872 1876 1872 1876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Kozar1">[44]</xref>
By genetic, biochemical and gene expression profile analyses, we show that immortalized FHL2-/- MEFs retain wt ARF and p53, implying alternative mechanisms for immortalization of FHL2-deficient cells. Although primary FHL2-/- MEFs undergo replicative senescence followed by emergence of immortalized variants with similar kinetics as in wt cells, immortalized FHL2-/- cell lines display unusual features. We first noticed dramatically reduced growth rate associated with down-regulation of cyclins D1, D2 and D3 (Fig. 5C and [5]). Spontaneous senescence occurs in the presence of mitogens [35]. Because D-type cyclins are critical cell cycle sensors of mitogens, decrease of all D-type cyclins may be sufficient for primary cells to bypass the growth arrest induced by the tissue culture environment. Such process might be selected in FHL2-deficient cells, with emergence of variants with low expression of cyclin D that may not fully sense hypermitogenic signals in the culture environment. By enabling cells to escape mitogen-induced senescence, this process might circumvent the need for loss of p53 or ARF. Thus in the absence of FHL2 signalling, we propose that decreasing sensitivity to mitogenic signals may, in part, account for an alternative mechanism of cell immortalization. This notion is supported by our observation that upon restoration of cyclin D1 expression in FHL2-/- cells, disabling the p53/ARF checkpoint becomes central to the establishment of cyclin D1-HA/FHL2-/- MEF lines as for wt cells. It suggests that the interplay between expression of mitogenic sensors and p53 functions might control cell growth or arrest in response to various stresses imposed by tissue culture. This hypothesis is consistent with previous observations showing that primary cyclin D1, D2 and D3 triple knock-out MEFs display reduced susceptibility to oncogenic agents [44].
###end p 49
###begin title 50
###xml 102 105 102 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
The integrity of the ARF/p53 pathway is responsible for Ras-induced cell cycle arrest in immortal FHL2-/- cell lines
###end title 50
###begin p 51
###xml 137 140 137 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 133 140 133 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 282 286 282 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 294 299 294 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 487 491 487 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Morales1">[45]</xref>
###xml 602 605 602 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 598 605 598 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KSR1<sup>&#8722;/&#8722;</sup></italic>
###xml 727 731 727 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Kortum1">[46]</xref>
###xml 740 743 740 743 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 736 743 736 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 1093 1096 1093 1096 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1089 1096 1089 1096 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 347 352 <span type="species:ncbi:9606">human</span>
###xml 496 502 <span type="species:ncbi:10090">murine</span>
Immortalization is thought to endow cells with sensitivity to oncogene-induced transformation. Instead, the response of immortalized FHL2-/- MEFs to oncogenic Ras was characterized by cell cycle arrest associated with a senescent-like morphology and significant increase in p53, p21CIP1 and p16INK4a. Similar findings have been reported in normal human fibroblasts in which ectopic telomerase expression was sufficient for immortalization, but the introduction of Ras induced senescence [45]. In murine systems, it has been shown that cell immortality alone is not sufficient for transformation of KSR1-/- cells by Ras, and that disruption of the MAP kinase scaffold protein KSR1 directly blocks transduction of the Ras signal [46]. In FHL2-/- MEFs, resistance to Ras-mediated transformation might rather reflect the integrity of the ARF/p53 checkpoint, which senses inappropriate mitogenic signals and diverts cells to p53-dependent cell cycle arrest. This notion is supported by our finding that impairment of p53 function by overexpression of E6 or p53DD restores the susceptibility of FHL2-/- cells to Ras-induced transformation.
###end p 51
###begin title 52
###xml 82 85 82 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Activation of cyclin D by Ras can override the p53-dependent growth arrest of FHL2-/- cells
###end title 52
###begin p 53
###xml 139 143 139 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Yu1">[43]</xref>
###xml 197 200 197 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 193 200 193 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 285 289 285 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Yu1">[43]</xref>
###xml 448 451 448 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 444 451 444 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 663 667 663 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Narita1">[27]</xref>
###xml 746 750 746 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Narita1">[27]</xref>
###xml 837 841 837 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Dirac1">[47]</xref>
###xml 1133 1138 1133 1138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 1143 1147 1143 1147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 1270 1274 1270 1274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Blagosklonny2">[48]</xref>
###xml 1371 1375 1371 1375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2</italic>
###xml 645 650 <span type="species:ncbi:9606">human</span>
###xml 728 733 <span type="species:ncbi:9606">human</span>
###xml 921 926 <span type="species:ncbi:10090">mouse</span>
###xml 975 980 <span type="species:ncbi:9606">human</span>
###xml 1070 1076 <span type="species:ncbi:10090">murine</span>
D-type cyclins represent the ultimate recipients of Ras oncogenic signal, and Ras can drive cell proliferation through all three D-cyclins [43]. Curiously, Ras activated all three D-cyclins in FHL2-/- cells, but failed to upregulate cyclins D2 and D3 in wt fibroblasts (this study and [43]), suggesting that FHL2 signalling has impact on all three D-cyclins. In turn, the dramatic increase in cyclin D led to efficient phosphorylation of Rb in FHL2-/- cells. The Rb tumor suppressor is required for senescence-associated heterochromatic foci (SAHF) formation and E2F target gene silencing, thus essential for the stability of senescent state in human fibroblasts [27]. However, SAHF formation in MEFs is less pronounced than in human fibroblasts [27] and senescent MEFs can rapidly re-enter cell cycle upon disruption of the p53 pathway [47]. These observations suggest that the control of the stability of senescence in mouse fibroblasts may be less dependent on Rb than in human fibroblasts and that p53 is required for both induction and maintenance of senescence in murine cells. It has been proposed that either inactivating p16INK4a, p21CIP1, p53 and Rb or re-activating cell cycle by c-myc, E2F, CDK2 and viral oncoproteins are required for overcoming senescence [48]. In the absence of p53 defects, the mechanisms involved in reversal of the cell cycle arrest in FHL2-deficient cells remain to be elucidated. A possible interpretation of our data might be that induction of G1-S cyclins by Ras eventually counteracts the p53-dependent proliferative block, leading to re-entry into the cell cycle and cell transformation.
###end p 53
###begin p 54
###xml 502 506 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Wang1">[22]</xref>
###xml 179 184 <span type="species:ncbi:9606">human</span>
###xml 511 516 <span type="species:ncbi:10090">mouse</span>
FHL2 provides a unique mechanism in transcellular coordination and signal transduction by shuttling between focal adhesions and the nucleus. The up-regulation of FHL2 observed in human cancers suggests a potential role of FHL2 in the oncogenic process. This study demonstrates that the absence of FHL2 signalling provides a brake to cell transformation in tissue culture system. Suppression of FHL2 by antisense and siRNA methods has been shown to inhibit growth of gastric and colon cancer cell lines [22]. In mouse model, loss of FHL2 markedly decreases intestinal polyp formation induced by activation of the Wnt/beta-catenin pathway (C.L., Y.N., F.L., S. Colnot, J. Chen, C. Perret, M.A.B. and Y.W., unpublished data). These results indicate that FHL2 signalling is important in the process of cell transformation and that its deficiency is benefitial for inhibition of this process. Treatment targeting FHL2 may thus provide a viable and specific strategy for cancer therapy.
###end p 54
###begin title 55
Materials and Methods
###end title 55
###begin title 56
Cell culture
###end title 56
###begin p 57
###xml 18 21 18 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 14 21 14 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
###xml 58 61 58 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Labalette1">[5]</xref>
###xml 208 209 208 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 143 149 <span type="species:ncbi:9913">bovine</span>
Wild type and FHL2-/- MEFs have been described previously [5]. Cells were cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal bovine serum. Cell proliferation was determined by plating 2.5x104 cells into 12-well plates in triplicate. Following initial plating, cells were harvested and counted for 6 days.
###end p 57
###begin title 58
Retroviral vectors and gene transfer
###end title 58
###begin p 59
###xml 210 214 210 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Hahn1">[42]</xref>
###xml 392 395 392 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Labalette1">[5]</xref>
pWZLH-RasV12hygro was kindly provided by Dr. Scott Lowe. The pBabe-E6neo and pBabeH-RasV12puro retroviral vectors were gifts from Dr. Oliver Bischof. The pBabe-hygro p53DD construct from Dr. Bob Weinberg's lab [42] and the pBabe-puro-cyclinD1-HA from Dr. William Hahn's lab were obtained from Addgene (Addgene plasmids 9058 and 9050 respectively). The pBabe-FHL2puro was described previously [5]. Phoenix ecotropic virus packaging cells in 10 cm-culture dishes were transfected by phosphate calcium precipitation with 10 microg of retroviral vector. After 48 h, the virus-containing medium was filtered and supplemented with 8 microg/ml polybrene. For infection, the culture medium of target fibroblasts was replaced by virus-containing medium and incubated at 37degreesC for 3 h. The infection process was repeated three times, followed by drug selection.
###end p 59
###begin title 60
Transformation assays and tumorigenesis
###end title 60
###begin p 61
###xml 43 44 43 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 143 147 139 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Schuermann1">[49]</xref>
###xml 716 717 712 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 891 898 887 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 931 932 927 928 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1011 1015 <span type="species:ncbi:10090">mice</span>
###xml 1095 1099 <span type="species:ncbi:10090">mice</span>
###xml 1337 1341 <span type="species:ncbi:10090">Mice</span>
For focus assays, cells were plated at 5x105 cells in 10-cm culture dish. Cells were either transfected with 10 microg of either pCMV-H-RasV12 [49] or empty vector by using lipofectamine (Invitrogen), or infected with pBabe-E6neo and pBabe without selection. Cells were fed twice weekly and stained with Giemsa 3 weeks later. To generate stable cell lines expressing Ras and p53DD, MEFs were infected with virus-containing supernatant derived from Phoenix packaging cells transfected with the retroviral vectors pWZLH-RasV12Hygro, pBabeH-RasV12puro, and pBabe-hygro p53DD, followed by drug selection. For soft agar assays, cells were resuspended in 0.3% agarose in DMEM supplemented with 10% FBS at a density of 5x104 cells per well in six-well plates and plated in triplicate onto solidified 0.6% agarose-containing medium. Colonies were counted and photographed 10 dyas after plating. For in vivo tumorigenesis assays, 5 to 10x106 cells were implanted s.c. into the flanks of 8 week old female athymic BALB/c mice (Charles River Laboratories). Tumor growth was monitored for 2 to 3 weeks, and mice were sacrificed when the maximal allowable tumor size was achieved. No tumor developped during an observation period of 10 weeks in control groups. All animal procedures were carried out in accordance with French government regulations. Mice were housed under pathogen-free conditions.
###end p 61
###begin title 62
Immunoblotting
###end title 62
###begin p 63
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Labalette2">[20]</xref>
###xml 321 325 321 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CIP1</sup>
###xml 344 349 344 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INK4a</sup>
###xml 452 455 452 455 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARF</sup>
Cellular extracts were prepared in lysis buffer (50 mM Tris-HCl pH 7.5, 250 mM NaCl; 0.5% NP-40; 250 mM EDTA; 1 mM DTT; protease inhibitor cocktail (Roche)). Proteins were analyzed by immunoblotting as described previously [20]. The following primary antibodies were used: anti-H-Ras (sc-29), anti-p53 (sc-6243), anti-p21CIP1 (sc-397), anti-p16INK4a (sc1207), anti-cyclin D1 (sc-450), cyclin D2 (sc-181) and cyclin D3 (sc-182) from Santa Cruz, anti-p19ARF (ab80) from Abcam, anti-Rb (554136) from BD Pharmingen, anti-FHL2 (K0055-3) from MBL, anti-HA (Babco) and anti-actin (Sigma).
###end p 63
###begin title 64
p53 induction and immunoprecipitation
###end title 64
###begin p 65
###xml 10 11 10 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
MEFs (1x106 cells per well) were treated with 1 microg/ml doxorubicin and lysed 24 h later in IP buffer (50 mM Tris-HCl pH 7.5, 300 mM NaCl; 0.5% Triton x100; 1 mM DTT; protease inhibitor cocktail (Roche)). The lysate was cleared by centrifugation and incubated with a mixture of monoclonal antibodies against p53 (0.5 microg; Pab 246 and Pab240, Santa Cruz) in the presence of protein A/G-Sepharose beads (Pierce). Proteins were analyzed by immunoblotting with anti-p53 antibody. Signals were quantified using Gene Snap/Gene Tools from SynGene.
###end p 65
###begin title 66
Direct PCR sequencing
###end title 66
###begin p 67
###xml 131 157 127 153 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGGTGCTTGGACAATGTGTT-3&#8242;</named-content>
###xml 172 198 168 194 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGACGCACAAACCAAAACAA-3&#8242;</named-content>
###xml 222 248 218 244 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GTAGGGAGCGACTTCACCTG-3&#8242;</named-content>
###xml 263 289 259 285 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CAGAAGCTGGGGAAGAAACA-3&#8242;</named-content>
###xml 316 342 312 338 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCTTGTGCTGGTCCTTTTCT-3&#8242;</named-content>
###xml 357 383 353 379 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATGCGAGAGACAGAGGCAAT-3&#8242;</named-content>
###xml 407 433 403 429 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGTCCAGTGCTTCCATCTCA-3&#8242;</named-content>
###xml 448 474 444 470 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGAGGGAGGTCTGGGTAGAG-3&#8242;</named-content>
###xml 499 525 495 521 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGTGATGATGGTGATGGTGA-3&#8242;</named-content>
###xml 540 566 536 562 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TATGGCGGGAAGTAGACTGG-3&#8242;</named-content>
###xml 690 713 686 709 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GTAAAACGACGGCCAGT-3&#8242;</named-content>
###xml 754 784 750 780 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CACACAGGAAACAGCTATGACCAT-3&#8242;</named-content>
DNA fragments spanning p53 exons 4-10 were amplified from 0.1-0.2 microg of genomic DNA with the following primers: for exons 4-5, 5'-TGGTGCTTGGACAATGTGTT-3' (forward) and 5'-AGACGCACAAACCAAAACAA-3' (reverse); for exon 6, 5'-GTAGGGAGCGACTTCACCTG-3' (forward) and 5'-CAGAAGCTGGGGAAGAAACA-3' (reverse); for exons 7-8, 5'-CCTTGTGCTGGTCCTTTTCT-3' (forward) and 5'-ATGCGAGAGACAGAGGCAAT-3' (reverse); for exon 9, 5'-TGTCCAGTGCTTCCATCTCA-3' (forward) and 5'-GGAGGGAGGTCTGGGTAGAG-3' (reverse); for exon 10, 5'-GGTGATGATGGTGATGGTGA-3' (forward) and 5'-TATGGCGGGAAGTAGACTGG-3' (reverse). For all exons, sequencing primers consisted of common sequences, are attached to the 5' end of forward primers (5'-GTAAAACGACGGCCAGT-3'), and to the 5' of the reverse primers (5'-CACACAGGAAACAGCTATGACCAT-3'). PCR products were purified by filtration on a MultiScreen(R)-HV plate (Millipore) loaded with Bio-Gel(R) P-100 Gel solution (Bio-Rad Laboratories). Nucleotide sequences were obtained from both ends using ABI PRISM BigDye Terminator sequencing kits and the 3130 Xl Genetic Analyzer (Applied Biosystems).
###end p 67
###begin title 68
Microarray analysis
###end title 68
###begin p 69
###xml 57 60 57 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Labalette1">[5]</xref>
###xml 67 71 67 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003761-Subramanian1">[37]</xref>
Microarray analysis was performed as previously reported [5]. GSEA [37] was used to evaluate the correlation of a specific gene list with two different sample groups (genotypes). We used the signal2noise ratio as a statistic to compare specific and gene set permutations in order to evaluate statistical differences. Microarray data have been deposited in NCBI Gene Expression Omnibus (GEO Series accession number: GSE10902).
###end p 69
###begin title 70
mRNA analysis
###end title 70
###begin p 71
###xml 39 42 39 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 35 42 35 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FHL2<sup>&#8722;/&#8722;</sup></italic>
Total RNA was isolated from wt and FHL2-/- MEFs with RNeasy minikit (Qiagen). 1 microg of RNA was reverse-transcribed using random primers and the Superscript Reverse Transcriptase (Invitrogen). The primer sequences used in real-time PCR are available upon request. The mean copy number of each gene from a triplicate determination was normalized to the mean copy number of 18S RNA.
###end p 71
###begin p 72
We thank M. Lassalle for technical advice and C. Neuveut for insightful discussion.
###end p 72
###begin title 73
References
###end title 73
###begin article-title 74
From the membrane to the nucleus and back again: bifunctional focal adhesion proteins.
###end article-title 74
###begin article-title 75
The LIM-only protein DRAL/FHL2 binds to the cytoplasmic domain of several alpha and beta integrin chains and is recruited to adhesion complexes.
###end article-title 75
###begin article-title 76
Focal adhesion kinase interacts with the transcriptional coactivator FHL2 and both are overexpressed in epithelial ovarian cancer.
###end article-title 76
###begin article-title 77
Deficiency in the LIM-only protein FHL2 impairs assembly of extracellular matrix proteins.
###end article-title 77
###begin article-title 78
The LIM-only protein FHL2 regulates cyclin D1 expression and cell proliferation.
###end article-title 78
###begin article-title 79
The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus.
###end article-title 79
###begin article-title 80
The LIM-only protein FHL2 is a serum-inducible transcriptional coactivator of AP-1.
###end article-title 80
###begin article-title 81
FHL2, a novel tissue-specific coactivator of the androgen receptor.
###end article-title 81
###begin article-title 82
A family of LIM-only transcriptional coactivators: tissue-specific expression and selective activation of CREB and CREM.
###end article-title 82
###begin article-title 83
The LIM-only protein DRAL/FHL2 interacts with and is a corepressor for the promyelocytic leukemia zinc finger protein.
###end article-title 83
###begin article-title 84
###xml 44 49 <span type="species:ncbi:9606">human</span>
SKI activates Wnt/beta-catenin signaling in human melanoma.
###end article-title 84
###begin article-title 85
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
The LIM-only protein FHL2 interacts with beta-catenin and promotes differentiation of mouse myoblasts.
###end article-title 85
###begin article-title 86
Identification of the LIM protein FHL2 as a coactivator of beta-catenin.
###end article-title 86
###begin article-title 87
Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation.
###end article-title 87
###begin article-title 88
Fhl2 deficiency results in osteopenia due to decreased activity of osteoblasts.
###end article-title 88
###begin article-title 89
The SRF target gene Fhl2 antagonizes RhoA/MAL-dependent activation of SRF.
###end article-title 89
###begin article-title 90
The LIM domain: from the cytoskeleton to the nucleus.
###end article-title 90
###begin article-title 91
Cardiac-specific LIM protein FHL2 modifies the hypertrophic response to beta-adrenergic stimulation.
###end article-title 91
###begin article-title 92
Deficiency in the LIM-only protein Fhl2 impairs skin wound healing.
###end article-title 92
###begin article-title 93
Interaction and functional cooperation between the LIM protein FHL2, CBP/p300 and beta-catenin.
###end article-title 93
###begin article-title 94
The LIM-only protein FHL2 is a negative regulator of E4F1.
###end article-title 94
###begin article-title 95
Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis.
###end article-title 95
###begin article-title 96
The multifunctional roles of the four-and-a-half-LIM only protein FHL2.
###end article-title 96
###begin article-title 97
FHL2 regulates cell cycle-dependent and doxorubicin-induced p21Cip1/Waf1 expression in breast cancer cells.
###end article-title 97
###begin article-title 98
Androgen induction of the androgen receptor coactivator four and a half LIM domain protein-2: evidence for a role for serum response factor in prostate cancer.
###end article-title 98
###begin article-title 99
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.
###end article-title 99
###begin article-title 100
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence.
###end article-title 100
###begin article-title 101
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF.
###end article-title 101
###begin article-title 102
Cellular senescence: mitotic clock or culture shock?
###end article-title 102
###begin article-title 103
FHL2 (SLIM3) is not essential for cardiac development and function.
###end article-title 103
###begin article-title 104
Ras signalling and apoptosis.
###end article-title 104
###begin article-title 105
###xml 38 43 <span type="species:ncbi:9606">human</span>
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
###end article-title 105
###begin article-title 106
###xml 12 17 <span type="species:ncbi:9606">human</span>
Reversal of human cellular senescence: roles of the p53 and p16 pathways.
###end article-title 106
###begin article-title 107
Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells.
###end article-title 107
###begin article-title 108
Cell senescence and hypermitogenic arrest.
###end article-title 108
###begin article-title 109
Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.
###end article-title 109
###begin article-title 110
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
###end article-title 110
###begin article-title 111
BRCA1 shifts p53-mediated cellular outcomes towards irreversible growth arrest.
###end article-title 111
###begin article-title 112
###xml 68 73 <span type="species:ncbi:9606">human</span>
Transcriptional regulation during p21WAF1/CIP1-induced apoptosis in human ovarian cancer cells.
###end article-title 112
###begin article-title 113
WAF1, a potential mediator of p53 tumor suppression.
###end article-title 113
###begin article-title 114
Oncogenic ras and p53 cooperate to induce cellular senescence.
###end article-title 114
###begin article-title 115
###xml 19 34 <span type="species:ncbi:10633">simian virus 40</span>
###xml 71 76 <span type="species:ncbi:9606">human</span>
Enumeration of the simian virus 40 early region elements necessary for human cell transformation.
###end article-title 115
###begin article-title 116
Ras and myc can drive oncogenic cell proliferation through individual D-cyclins.
###end article-title 116
###begin article-title 117
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse development and cell proliferation in the absence of D-cyclins.
###end article-title 117
###begin article-title 118
###xml 40 45 <span type="species:ncbi:9606">human</span>
Absence of cancer-associated changes in human fibroblasts immortalized with telomerase.
###end article-title 118
###begin article-title 119
The molecular scaffold KSR1 regulates the proliferative and oncogenic potential of cells.
###end article-title 119
###begin article-title 120
###xml 26 31 <span type="species:ncbi:10090">mouse</span>
Reversal of senescence in mouse fibroblasts throug lentiviral suppression of p53.
###end article-title 120
###begin article-title 121
Cell senescence: hypertrophic arrest beyond the restriction point.
###end article-title 121
###begin article-title 122
An expression vector system for stable expression of oncogenes.
###end article-title 122
###begin p 123
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 123
###begin p 124
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported in part by grants from the Association pour la Recherche sur le Cancer, the Ligue contre le Cancer (Comite de Paris) and the Institut National du Cancer. C.L. was supported by the Ecole Normale Superieure de Lyon and Y.N. by the Canceropole Ile-de-France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 124

